Nifty

:

25044.65

Sensex

:

81106.65

58.25 (0.23%)
107.25 (0.13%)

Login

Nifty
Sensex

:
:

25044.65
81106.65

58.25 (0.23%)
107.25 (0.13%)

Krebs Biochemicals & Industries Ltd.

Pharmaceuticals & Drugs

Rating :

53/99

BSE: 524518 | NSE: KREBSBIO

Watchlist

NSE BSE

59.62

09-Nov-2026

Open
High
Low
Previous Close

58.6
61.99
58.06
57.50

Volume
Traded Value (lacs)
52 Week High
52 Week Low

16627
993240.29
76.85
38.33

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

126.52
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

353.38
N/A
-0.74

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

20.99
-16.85
-22.21

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-3.77
-30.66
-8.99

PAT CAGR (%)

10 Years
5 Years
3 Years

0.54
-17.59
-4.97

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-3.57
-2.02
-1.17

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-49.55
-67.72
-101.78

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 26 Sep 25 Var% Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var%
Net Sales 5.79 4.17 38.85% 6.98 5.48 27.37% 6.81 6.10 11.64% 7.27 11.47 -36.62%
Expenses 7.72 6.96 10.92% 6.16 7.57 -18.63% 7.68 11.51 -33.28% 6.98 16.18 -56.86%
EBITDA -1.93 -2.79 - 0.83 -2.09 - -0.87 -5.41 - 0.30 -4.72 -
EBIDTM -33.32% -67.03% 11.83% -38.08% -12.75% -88.64% 4.10% -41.13%
Other Income 0.04 0.01 300.00% 0.16 0.01 1,500.00% 2.00 0.34 488.24% 0.00 0.25 -100.00%
Interest 1.90 1.73 9.83% 1.88 1.65 13.94% 1.91 1.61 18.63% 1.79 1.56 14.74%
Depreciation 1.61 1.62 -0.62% 1.59 1.60 -0.62% 1.57 1.57 0.00% 1.64 1.72 -4.65%
PBT -5.40 -6.14 - -2.49 -5.32 - -2.34 -8.25 - -3.13 -7.74 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.02 -100.00% 0.00 0.00 0
PAT -5.40 -6.14 - -2.49 -5.32 - -2.34 -8.27 - -3.13 -7.74 -
PATM -93.25% -147.42% -35.60% -97.14% -34.37% -135.54% -42.98% -67.49%
EPS -2.50 -2.84 - -1.15 -2.46 - -1.08 -3.83 - -1.45 -3.58 -

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 26.85 23.73 43.31 50.42 52.13 59.70 53.70 33.41 47.76 33.78 3.53 Net Sales Growth -1.36% -45.21% -14.10% -3.28% -12.68% 11.17% 60.73% -30.05% 41.39% 856.94% Cost Of Goods Sold 1.80 0.39 5.56 6.59 25.68 40.64 25.94 15.86 23.10 12.67 1.20 Gross Profit 25.05 23.34 37.76 43.83 26.46 19.06 27.75 17.55 24.65 21.10 2.33 GP Margin 93.30% 98.36% 87.19% 86.93% 50.76% 31.93% 51.68% 52.53% 51.61% 62.46% 66.01% Total Expenditure 28.54 29.18 58.34 59.15 67.91 93.70 71.28 51.97 57.52 41.28 11.53 Power & Fuel Cost - 9.61 18.52 22.01 14.80 22.23 15.91 10.28 11.70 8.62 0.70 % Of Sales - 40.50% 42.76% 43.65% 28.39% 37.24% 29.63% 30.77% 24.50% 25.52% 19.83% Employee Cost - 10.09 16.30 16.17 15.54 14.96 15.30 14.56 14.41 11.49 5.63 % Of Sales - 42.52% 37.64% 32.07% 29.81% 25.06% 28.49% 43.58% 30.17% 34.01% 159.49% Manufacturing Exp. - 3.69 14.53 11.25 8.48 11.11 10.37 6.77 4.09 4.59 1.07 % Of Sales - 15.55% 33.55% 22.31% 16.27% 18.61% 19.31% 20.26% 8.56% 13.59% 30.31% General & Admin Exp. - 3.26 3.35 3.03 3.25 4.47 3.47 4.05 4.05 3.76 2.88 % Of Sales - 13.74% 7.73% 6.01% 6.23% 7.49% 6.46% 12.12% 8.48% 11.13% 81.59% Selling & Distn. Exp. - 0.05 0.08 0.09 0.16 0.27 0.14 0.16 0.13 0.13 0.05 % Of Sales - 0.21% 0.18% 0.18% 0.31% 0.45% 0.26% 0.48% 0.27% 0.38% 1.42% Miscellaneous Exp. - 2.10 0.00 0.00 0.00 0.00 0.13 0.29 0.02 0.02 0.05 % Of Sales - 8.85% 0% 0% 0% 0% 0.24% 0.87% 0.04% 0.06% 0.28% EBITDA -1.67 -5.45 -15.03 -8.73 -15.78 -34.00 -17.58 -18.56 -9.76 -7.50 -8.00 EBITDA Margin -6.22% -22.97% -34.70% -17.31% -30.27% -56.95% -32.74% -55.55% -20.44% -22.20% -226.63% Other Income 2.20 2.03 0.71 0.45 0.62 1.16 0.62 0.37 0.33 0.21 0.08 Interest 7.48 7.09 5.91 4.69 2.97 5.39 6.28 6.00 6.29 5.17 3.49 Depreciation 6.41 6.42 6.69 6.77 6.56 6.30 5.12 4.68 4.40 4.15 4.23 PBT -13.36 -16.93 -26.92 -19.73 -24.69 -44.53 -28.36 -28.87 -20.12 -16.61 -15.65 Tax 0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Rate 0.00% 0.00% -0.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% PAT -13.36 -16.93 -26.94 -19.73 -24.69 -44.53 -28.36 -28.87 -20.01 -17.82 -16.05 PAT before Minority Interest -13.36 -16.93 -26.94 -19.73 -24.69 -44.53 -28.36 -28.87 -20.01 -17.82 -16.05 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -49.76% -71.34% -62.20% -39.13% -47.36% -74.59% -52.81% -86.41% -41.90% -52.75% -454.67% PAT Growth 0.00% - - - - - - - - - EPS -6.19 -7.84 -12.47 -9.13 -11.43 -20.62 -13.13 -13.37 -9.26 -8.25 -7.43

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds -162.75 -146.24 -119.22 -99.46 -75.09 -42.73 -25.00 -14.29 -17.78 1.48 Share Capital 21.56 21.56 21.56 21.56 21.56 19.62 18.00 16.63 13.74 13.74 Total Reserves -184.32 -167.80 -140.78 -121.02 -96.65 -66.52 -50.65 -30.92 -31.52 -12.27 Non-Current Liabilities 212.94 211.75 235.56 225.34 186.83 153.76 115.66 101.79 101.37 88.88 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.89 5.03 Unsecured Loans 163.55 161.25 183.50 173.25 132.93 100.55 65.51 50.23 49.78 37.76 Long Term Provisions 2.78 3.06 3.05 2.60 2.63 2.56 2.46 4.04 3.68 2.82 Current Liabilities 113.07 103.53 61.83 49.10 78.06 48.19 43.13 54.86 42.28 31.72 Trade Payables 13.76 18.15 18.97 15.28 37.91 20.78 22.65 21.44 17.76 10.99 Other Current Liabilities 37.32 33.63 31.87 22.57 29.01 15.92 18.50 32.00 23.27 19.86 Short Term Borrowings 61.29 50.96 9.93 9.99 9.99 10.00 0.00 0.00 0.00 0.00 Short Term Provisions 0.70 0.79 1.06 1.26 1.17 1.49 1.99 1.43 1.25 0.87 Total Liabilities 163.26 169.04 178.17 174.98 189.80 159.22 133.79 142.36 125.87 122.08 Net Block 141.71 145.70 149.96 147.31 138.71 117.93 105.29 101.27 100.77 102.17 Gross Block 314.01 314.11 312.46 303.04 287.95 260.88 243.11 234.41 229.51 226.55 Accumulated Depreciation 172.30 168.40 162.50 155.73 149.25 142.95 137.82 133.15 128.74 124.38 Non Current Assets 153.62 158.78 160.73 158.92 154.31 137.80 114.94 111.39 108.64 109.10 Capital Work in Progress 1.59 3.09 2.00 4.09 8.38 11.94 4.19 3.48 3.73 3.50 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 10.33 9.98 8.77 7.52 7.23 7.71 5.24 6.22 3.72 3.23 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.23 0.21 0.42 0.41 0.20 Current Assets 9.62 10.26 17.44 16.06 35.49 21.42 18.86 30.98 17.24 12.97 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 5.70 6.03 9.80 11.95 25.56 16.60 15.00 8.96 11.73 5.45 Sundry Debtors 0.00 0.05 1.90 0.53 0.88 0.30 0.20 2.91 0.32 1.59 Cash & Bank 0.13 0.14 0.14 0.09 0.10 0.71 0.17 17.32 0.42 0.12 Other Current Assets 3.79 0.65 0.54 0.65 8.95 3.80 3.49 1.78 4.77 5.81 Short Term Loans & Adv. 3.27 3.39 5.06 2.85 8.36 3.33 3.18 1.57 4.44 5.67 Net Current Assets -103.44 -93.27 -44.39 -33.04 -42.57 -26.77 -24.27 -23.88 -25.04 -18.74 Total Assets 163.24 169.04 178.17 174.98 189.80 159.22 133.80 142.37 125.88 122.07

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity -1.92 -7.89 2.36 -24.71 -17.22 -14.57 -35.50 3.90 -6.19 -11.20 PBT -16.93 -26.92 -19.73 -24.69 -44.53 -28.36 -28.87 -20.12 -16.61 -16.05 Adjustment 13.89 12.41 11.88 9.82 11.41 11.68 8.95 10.31 6.46 10.67 Changes in Working Capital 1.12 6.64 10.21 -9.84 15.90 2.11 -15.58 13.71 9.12 -2.33 Cash after chg. in Working capital -1.92 -7.88 2.36 -24.71 -17.22 -14.57 -35.50 3.90 -1.02 -7.71 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -5.17 -3.49 Tax Paid 0.00 -0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -3.64 -4.97 -7.82 -12.64 -22.90 -22.55 -10.22 -4.32 -2.77 -4.70 Net Fixed Assets 1.60 -2.74 -7.33 -10.80 -23.51 -25.52 -9.41 -4.65 -3.19 -6.27 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -5.24 -2.23 -0.49 -1.84 0.61 2.97 -0.81 0.33 0.42 1.57 Cash from Financing Activity 5.54 12.86 5.50 37.34 39.51 37.66 28.58 17.32 9.26 15.75 Net Cash Inflow / Outflow -0.01 0.00 0.05 -0.01 -0.61 0.54 -17.14 16.90 0.30 -0.15 Opening Cash & Equivalents 0.14 0.14 0.09 0.10 0.71 0.17 17.32 0.42 0.12 0.27 Closing Cash & Equivalent 0.13 0.14 0.14 0.09 0.10 0.71 0.17 17.32 0.42 0.12

Financial Ratios

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) -75.49 -67.83 -55.29 -46.13 -34.83 -23.91 -18.14 -8.59 -12.49 1.04 ROA -10.19% -15.52% -11.17% -13.54% -25.51% -19.36% -20.91% -14.92% -14.38% -13.46% ROE 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -296.70% ROCE -15.38% -29.92% -18.99% -28.59% -57.38% -40.28% -56.96% -35.41% -28.95% -27.13% Fixed Asset Turnover 0.08 0.14 0.16 0.18 0.22 0.21 0.14 0.21 0.15 0.02 Receivable days 0.42 8.23 8.79 4.91 3.60 1.71 17.00 12.36 10.34 83.55 Inventory Days 90.24 66.69 78.69 131.30 128.88 107.38 130.87 79.07 92.84 573.34 Payable days 0.00 1219.44 948.90 378.02 263.51 305.42 148.85 123.16 120.44 290.43 Cash Conversion Cycle 90.66 -1144.52 -861.42 -241.81 -131.03 -196.34 -0.98 -31.73 -17.27 366.46 Total Debt/Equity -1.38 -1.45 -1.62 -1.84 -1.91 -2.37 -2.03 -3.74 -3.16 32.19 Interest Cover -1.39 -3.55 -3.21 -7.30 -7.26 -3.52 -3.81 -2.18 -2.45 -3.60

Top Investors:

sun pharmaceutical industries ltd

guttikonda rajasekhar

guttikonda vara lakshmi

Annual Reports:

News Update:

Krebs Biochem.&Inds - Quarterly Results
30th Oct 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback